Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 Annex A A.17: Difference between revisions
From GxPlex
imported>GxPlexBot Import from GxPlex Excel |
Gxplex admin (talk | contribs) m 1 revision imported |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{ReferenceData | ||
| | |has_document=Document:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 | ||
| | |module=6 | ||
| | |unit=6.5.0 | ||
|scope=MD | |||
|doc_part=Annex A | |||
A.17 | A.17 | ||
| | |language=EN | ||
| | |entry_by=Florian Adragna | ||
| | |contributors= | ||
| | |tags=TAG-00075-Pub-ich ++ TAG-00265-Cli-tud ++ TAG-00203-Cli-lin ++ TAG-00201-Cli-eSt | ||
|tags_display=[[Glossary:TAG-00075-Pub-ich|Publication]], [[Glossary:TAG-00265-Cli-tud|ClinicalTrials.gov]], [[Glossary:TAG-00203-Cli-lin|Investigation plan]], [[Glossary:TAG-00201-Cli-eSt|Clinical investigation]] | |||
|comment=Publication policy and trial registration statement in CIP | |||
|content=A.17 Publication policy | |||
[…] | |||
}} | }} | ||
Latest revision as of 13:50, 16 July 2026
| Document information | |
|---|---|
| Reference | ISO ISO 14155 -
Clinical investigation of medical devices for human subjects 2020 |
| Validity area | ISO |
| Scope(s) | MD |
| Document name | ISO 14155 -
Clinical investigation of medical devices for human subjects |
| Version / Revision | 2020 |
| Status | Current |
| Document type | International guideline |
| Language(s) | EN |
| Description | ISO 14155:2020
Clinical investigation of medical devices for human subjects — Good clinical practice |
| Official source | Official link |
| Restricted access | Yes |
| Submitted by | Florian Adragna |
| Contributors | |
| Reference Details | |
|---|---|
| Module | Module 6 — Unit 6.5.0 |
| Scope | MD |
| Document part | Annex A
A.17 |
| Language | EN |
| Original entry by | Florian Adragna |
| Contributors | |
| Tags | Publication, ClinicalTrials.gov, Investigation plan, Clinical investigation |
Content
A.17 Publication policy […]